Log In
BCIQ
Print this Print this
 

ProZ92 (Z-92)

  Manage Alerts
Collapse Summary General Information
Company Psoraya Pharmaceuticals Ltd.
DescriptionTopical plant extract epidermal keratinocyte inhibitor
Molecular Target Keratinocyte growth factor (KGF) receptor (KGFR) (FGFR2) (CD332)
Mechanism of ActionNA
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationPsoriasis
Indication DetailsTreat psoriasis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today